These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD. J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056 [Abstract] [Full Text] [Related]
5. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient? Park SH, Park HY, Kang JW, Park JS, Shin KJ, Kim CH, Suk KT, Baik GH, Kim JB, Kim DJ, Lee HY. Hepatogastroenterology; 2012 Aug; 59(120):2548-51. PubMed ID: 23178621 [Abstract] [Full Text] [Related]
6. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]. Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH. Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762 [Abstract] [Full Text] [Related]
7. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Rincon D, Lo Iacono O, Ripoll C, Gomez-Camarero J, Salcedo M, Catalina MV, Hernando A, Clemente G, Matilla A, Nuñez O, Bañares R. Aliment Pharmacol Ther; 2007 Apr 01; 25(7):841-8. PubMed ID: 17373923 [Abstract] [Full Text] [Related]
8. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. J Hepatol; 2005 Jun 01; 42(6):826-32. PubMed ID: 15885353 [Abstract] [Full Text] [Related]
9. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis. Suk KT, Kim CH, Park SH, Sung HT, Choi JY, Han KH, Hong SH, Kim DY, Yoon JH, Kim YS, Baik GH, Kim JB, Kim DJ. J Clin Gastroenterol; 2012 Jun 01; 46(10):880-6. PubMed ID: 22810110 [Abstract] [Full Text] [Related]
11. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, Lee FY, Lee SD. Liver Int; 2007 May 01; 27(4):498-506. PubMed ID: 17403190 [Abstract] [Full Text] [Related]
13. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ. J Gastroenterol Hepatol; 2009 Sep 01; 24(9):1547-53. PubMed ID: 19686416 [Abstract] [Full Text] [Related]
14. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD. Liver Transpl; 2008 Jun 01; 14(6):837-44. PubMed ID: 18508377 [Abstract] [Full Text] [Related]
15. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score. Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Eur J Clin Invest; 2009 Jan 01; 39(1):65-71. PubMed ID: 19087131 [Abstract] [Full Text] [Related]
16. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis. Mathur S, Gane EJ, McCall JL, Plank LD. J Gastroenterol Hepatol; 2008 Feb 01; 23(2):239-43. PubMed ID: 17489965 [Abstract] [Full Text] [Related]
17. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, Borzio M, Redaelli A, Chiesa A, Silini EM, Almasio PL, Maisonneuve P. Am J Gastroenterol; 2009 May 01; 104(5):1147-58. PubMed ID: 19352340 [Abstract] [Full Text] [Related]
18. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey. Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD. Dig Liver Dis; 2008 Nov 01; 40(11):882-9. PubMed ID: 18339595 [Abstract] [Full Text] [Related]
19. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep 01; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
20. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF. J Viral Hepat; 2009 Jul 01; 16(7):464-70. PubMed ID: 19413694 [Abstract] [Full Text] [Related] Page: [Next] [New Search]